Lv1
60 积分 2024-01-23 加入
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer
2个月前
已关闭
Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy
4个月前
已完结
Clinical practice guidelines for management of medullary thyroid carcinoma: An AGREE II appraisal
5个月前
已完结
Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument
5个月前
已关闭
Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach
10个月前
已完结
皖公网安备34019202002308
